Skip to main content

Table 3 Univariable and multivariable analyses of factors associated with overall survival in the full cohort, women and men

From: Modifying effect of gender on the prognostic value of clinicopathological factors and Ki67 expression in melanoma: a population-based cohort study

Overall

Univariable

Multivariable

All HR(95%CI)

Women HR(95%CI)

Men HR(95%CI)

All HR(95%CI)

Women HR(95%CI)

Men HR(95%CI)

Age

      

Continuous

1.09 (1.04-1.13)

1.08 (1.02-1.15)

1.08 (1.02--1.14)

1.07 (1.02-1.13)

1.09 (1.02-1.16)

1.10 (1.02-1.18)

Sex

      

Women

1.00

-

-

1.00

-

-

Men

2.60 (1.47-4.61)

-

-

1.89 (0.95-3.79)

-

-

Histological subtype

      

LMM + SSM

1.00

1.00

1.00

1.00

1.00

1.00

NMM

3.86 (2.21-6.74)

3.93 (1.54-10.03)

4.17 (2.06-8.44)

2.73 (1.38-5.40)

3.35 (1.25-8.95)

2.88 (1.21-6.84)

Breslow thickness

      

<=1 mm

1.00

1.00

1.00

1.00

1.00

1.00

> 1 mm

4.17 (2.38-7.32)

4.53 (1.74-11.79)

3.66 (1.83-7.34)

0.73 (0.16-3.42)

0.56 (0.04-7.58)

0.58 (0.08-4.28)

Clark level

      

II-III

1.00

1.00

1.00

1.00

1.00

1.00

IV-V

2.27 (1.28-4.05)

1.87 (0.66-5.25)

2.22 (1.11-4.44)

0.84 (0.36-1.92)

0.53 (0.15-1.88)

1.10 (0.35-3.41)

Ulceration

      

No

1.00

1.00

1.00

1.00

1.00

1.00

Yes

6.29 (4.46-11.45)

5.83 (2.14-15.85)

7.33 (3.44-15.62)

2.63 (1.19-5.83)

1.01 (0.18-5.76)

3.34 (1.30-8.60)

Clinical stage

      

1

1.00

1.00

1.00

1.00

1.00

1.00

2-4

6.48 (3.05-13.73)

5.48 (1.43-21.04)

6.34 (2.49-16.14)

1.71 (0.57-5.08)

2.54 (0.59-10.89)

0.59 (0.11-3.29)

Vascular invasion

      

No

1.00

1.00

1.00

1.00

1.00

1.00

Yes

4.89 (2.38-4.08)

13.43 (2.84-63.50)

2.82 (1.23-6.50)

4.54 (1.90-10.84)

19.95 (3.63-109.75)

4.89 (1.66-14.41)

Mitotic count

      

0/mm2

1.00

1.00

1.00

1.00

1.00

1.00

> = 1/mm2

2.96 (1.66-5.28)

3.54 (1.26-9.96)

2.86 (1.41-5.82)

1.49 (0.65-3.40)

1.63 (0.34-7.81)

1.34 (0.44-4.07)

Lymphocytic infiltrate

      

None-mild

1.00

1.00

1.00

1.00

1.00

1.00

Moderate-brisk

0.46 (0.26-0.79)

0.53 (0.17-1.09)

0.45 (0.22-0.90)

0.66 (0.35-1.25)

1.03 (0.30-3.49)

0.60 (0.27-1.35)

Ki67 expression

      

0-25%

1.00

1.00

1.00

1.00

1.00

1.00

>25%

1.97 (1.06-3.64)

1.79 (0.66-4.87)

2.38 (1.09-5.22)

1.55 (0.73-3.30)

1.46 (0.34-6.14)

2.65 (1.08-6.52)

  1. LMM = lentigo maligna melanoma, SSM = superficial spreading melanoma, NMM = nodular malignant melanoma.